ReviewDrugs in context2018
The biosimilars journey: current status and ongoing challenges.
Igor Age Kos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewDrugs in context2018
Igor Age Kos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.